William T. Andrews insider trades
Open-market stock purchases and sales by William T. Andrews, Chief Medical Officer at Catalyst Pharmaceuticals, Inc, from SEC Form 4 filings since Apr 1, 2015.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jul 15, 2026 | CPRX Catalyst Pharmaceuticals, Inc | Sold (not open market) | $72.7K |
| Jul 15, 2026 | CPRX Catalyst Pharmaceuticals, Inc | Sold (not open market) | — |
| Jul 15, 2026 | CPRX Catalyst Pharmaceuticals, Inc | Sold (not open market) | — |
| Jul 15, 2026 | CPRX Catalyst Pharmaceuticals, Inc | Sold (not open market) | — |
| Jul 15, 2026 | CPRX Catalyst Pharmaceuticals, Inc | Sold (not open market) | — |
| Jun 3, 2026 | CPRX Catalyst Pharmaceuticals, Inc | Bought (not open market) | — |
| Jun 3, 2026 | CPRX Catalyst Pharmaceuticals, Inc | Sold (not open market) | — |
| Nov 20, 2025 | CPRX Catalyst Pharmaceuticals, Inc | Bought (not open market) | — |
| Nov 20, 2025 | CPRX Catalyst Pharmaceuticals, Inc | Bought (not open market) | — |
Companies traded
- CPRX Catalyst Pharmaceuticals, Inc: other filings, last Jul 15, 2026
- FLXN Flexion Therapeutics Inc: other filings, last Nov 19, 2021
- AKCA Akcea Therapeutics, Inc: other filings, last Oct 12, 2020
- ACER Acer Therapeutics Inc: other filings, last Mar 2, 2020
- AEGR Aegerion Pharmaceuticals, Inc: other filings, last Aug 4, 2015